Skip to search formSkip to main contentSkip to account menu

Secondary Prevention

Known as: prevention secondary, Preventions, Secondary, Secondary Preventions 
Procedures or treatment processes designed to prevent complications (e.g., modifying a drug or surgical procedure to prevent complications).
National Institutes of Health

Related topics

Related topics

10 relations
ChemopreventionClinical Data Interchange Standards Consortium TerminologyEarly Intervention (Education)Early Therapy
Expand

Narrower (1)

Harm Reduction

Broader (1)

disease prevention

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
CONTEXT Antioxidant supplements are used for prevention of several diseases. OBJECTIVE To assess the effect of antioxidant… 
Review
2006
Review
2006
Health benefits of physical activity: the evidence
The primary purpose of this narrative review was to evaluate the current literature and to provide further insight into the role… 
Highly Cited
2005
Highly Cited
2005
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
CONTEXT Evidence suggests that more intensive lowering of low-density lipoprotein cholesterol (LDL-C) than is commonly applied… 
Review
2005
Review
2005
Meta-Analysis: Secondary Prevention Programs for Patients with Coronary Artery Disease
Cardiovascular disease remains the most common cause of office visits, hospitalizations, and death in the United States: More… 
Review
2003
Review
2003
Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
fatty acids affect cardiac function (including antiarrhythmic effects), hemodynamics (cardiac mechanics), and arterial… 
Review
2001
Review
2001
Cardiac rehabilitation and secondary prevention of coronary heart disease.
  • P. Ades
  • The New England journal of medicine
  • 2001
  • Corpus ID: 33633269
Coronary heart disease is the leading cause of death in the United States among men and women.1 It is also a major cause of… 
Highly Cited
1999
Highly Cited
1999
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
Context.—Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen… 
Highly Cited
1999
Highly Cited
1999
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention…
BACKGROUND Although it is generally accepted that lowering elevated serum levels of low-density lipoprotein (LDL) cholesterol in… 
Highly Cited
1998
Highly Cited
1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
CONTEXT Observational studies have found lower rates of coronary heart disease (CHD) in postmenopausal women who take estrogen… 
Highly Cited
1989
Highly Cited
1989
EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License